<DOC>
	<DOCNO>NCT01125553</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The aim trial compare exposure two formulation insulin degludec/insulin aspart ( NN5401 ) healthy subject .</brief_summary>
	<brief_title>A Comparison Between Two Formulations NN5401 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Considered generally healthy upon completion medical history , physical examination , vital sign electrocardiogram ( ECG ) , judge physician Body mass index 18.0 27.0 kg/m^2 ( inclusive ) Subject donate blood plasma past month 500 mL within 3 month prior trial start Smoker ( define subject smoke 5 cigarette equivalent per day ) Not able willing refrain smoking use nicotine gum transdermal nicotine patch inpatient period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>